142 related articles for article (PubMed ID: 15867822)
1. Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis.
Burdett S; Stewart L; Pignon JP
J Thorac Cardiovasc Surg; 2005 May; 129(5):1205; author reply 1205-6. PubMed ID: 15867822
[No Abstract] [Full Text] [Related]
2. Negative data from lung cancer trial may change practice guidelines, study designs.
McNeil C
J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
[No Abstract] [Full Text] [Related]
3. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
[TBL] [Abstract][Full Text] [Related]
4. Platinums in lung cancer: sufficient or necessary?
Bunn PA
J Clin Oncol; 2005 May; 23(13):2882-3. PubMed ID: 15728220
[No Abstract] [Full Text] [Related]
5. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
McCulloch M; See C; Shu XJ; Broffman M; Kramer A; Fan WY; Gao J; Lieb W; Shieh K; Colford JM
J Clin Oncol; 2006 Jan; 24(3):419-30. PubMed ID: 16421421
[TBL] [Abstract][Full Text] [Related]
6. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
Scagliotti GV
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
Socinski MA
J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
[No Abstract] [Full Text] [Related]
9. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
Tiseo M; Boni L; Ardizzoni A
J Clin Oncol; 2005 Sep; 23(25):6276-7; author reply 6277-8. PubMed ID: 16135504
[No Abstract] [Full Text] [Related]
10. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in non-small-cell lung cancer: an update of an individual patient data meta-analysis.
Burdett S; Stewart L; Auperin A; Pignon JP
J Clin Oncol; 2005 Feb; 23(4):924-5; author reply 925-6. PubMed ID: 15681545
[No Abstract] [Full Text] [Related]
12. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for non-small-cell lung cancer.
Pisters KM
Clin Adv Hematol Oncol; 2003 Sep; 1(9):533-7. PubMed ID: 16258445
[TBL] [Abstract][Full Text] [Related]
14. [Non-small cell bronchial carcinoma. A conceptual evolution].
Depierre A
Rev Pneumol Clin; 1991; 47(4):153-4. PubMed ID: 1663653
[No Abstract] [Full Text] [Related]
15. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
[TBL] [Abstract][Full Text] [Related]
16. Silk purse in Atlanta: a commentary on SWOG 9509, an advanced non-small cell lung cancer trial.
Gralla RJ
Oncologist; 1999; 4(3):188-90. PubMed ID: 10394586
[No Abstract] [Full Text] [Related]
17. [Current status of adjuvant chemotherapy for the resected non-small cell lung cancer].
Tsuboi M; Kato H
Nihon Rinsho; 2002 May; 60 Suppl 5():329-34. PubMed ID: 12101682
[No Abstract] [Full Text] [Related]
18. Optimal therapy for unresectable stage III non-small-cell lung cancer.
Vokes EE
J Clin Oncol; 2005 Sep; 23(25):5853-5. PubMed ID: 16087940
[No Abstract] [Full Text] [Related]
19. [Chemotherapy of advanced non-small cell lung neoplasms: a closed debate?].
Le Guen Y; Soria JC; Ruffié P
Bull Cancer; 2003 Mar; 90(3):199-201. PubMed ID: 12801821
[No Abstract] [Full Text] [Related]
20. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
